Filter Results:
(398)
Show Results For
- All HBS Web
(398)
- News (48)
- Research (309)
- Multimedia (1)
- Faculty Publications (246)
Show Results For
- All HBS Web
(398)
- News (48)
- Research (309)
- Multimedia (1)
- Faculty Publications (246)
- October 2007
- Article
Realizing the Promise of Personalized Medicine
By: Mara G. Aspinall and Richard G. Hamermesh
Keywords: Health
Aspinall, Mara G., and Richard G. Hamermesh. "Realizing the Promise of Personalized Medicine." Harvard Business Review 85, no. 10 (October 2007).
- May 2018
- Case
The Multiple Myeloma Research Foundation's Answer Fund
By: Richard G. Hamermesh and Matthew G. Preble
Keywords: Data Analytics; Customer Focus and Relationships; Customer Relationship Management; Cost vs Benefits; Investment Return; Health Care and Treatment; Innovation Leadership; Intellectual Property; Knowledge Sharing; Knowledge Dissemination; Leadership; Leading Change; Resource Allocation; Goals and Objectives; Marketing Communications; Performance; Programs; Projects; Business and Community Relations; Business and Stakeholder Relations; Networks; Partners and Partnerships; Research and Development; Genetics; Behavior; Motivation and Incentives; Social and Collaborative Networks; Nonprofit Organizations; Strategy; Health Industry; Pharmaceutical Industry; Biotechnology Industry; United States
- 01 Mar 2013
- News
Health-Care Forum's Rx for US System
event was chaired by HBS professors Richard Hamermesh and Robert Huckman, with colleagues from Harvard University and Harvard Medical School. The goal of the gathering and the... View Details
Keywords: Health, Social Assistance
- November 1981 (Revised May 1985)
- Case
General Electric: Business Development
By: Francis Aguilar and Richard G. Hamermesh
Aguilar, Francis, and Richard G. Hamermesh. "General Electric: Business Development." Harvard Business School Case 382-092, November 1981. (Revised May 1985.)
- September 30, 2020
- Article
How Nonprofit Foundations Can Sustainably Fund Disease Research
By: Richard G. Hamermesh and Kathy Giusti
Hamermesh, Richard G., and Kathy Giusti. "How Nonprofit Foundations Can Sustainably Fund Disease Research." Harvard Business Review Digital Articles (September 30, 2020).
- November 12, 2018
- Article
Precision Medicine Has Transformed Cancer Treatment. Here's How to Move It Beyond Oncology
By: Richard G. Hamermesh and Kathy Giusti
Hamermesh, Richard G., and Kathy Giusti. "Precision Medicine Has Transformed Cancer Treatment. Here's How to Move It Beyond Oncology." Fortune.com (November 12, 2018).
- 6 Jan 2016
- Interview
A Microchip in Your Medicine
By: Richard G. Hamermesh and Brian Kenny
"A Microchip in Your Medicine." Cold Call (podcast), Harvard Business Review Group, January 6, 2016.
- May 2017
- Teaching Plan
Neurotrack and the Alzheimer's Puzzle
By: Richard G. Hamermesh and Carin-Isabel Knoop
Teaching Note for HBS No. 816-072. View Details
- October 2013
- Case
FasterCures: Removing Barriers to Treatments
By: Richard G. Hamermesh and James Weber
In mid-2013, as FasterCures celebrated its 10th anniversary as a center of the Milken Institute, Executive Director Margaret Anderson thought about what the organization should do to ensure it had even more impact in its next 10 years. FasterCures was a non-profit... View Details
Keywords: Health Care; Health Care Industry; Health Care Policy; Health Services; Healthcare; Healthcare Reform; Healthcare Ventures; Nonprofit; Non-profit Management; Not-for-profit; Incubator; Accelerator; Venture Philanthropy; Medical Services; Medical Solutions; Medical Research; Medical Treatment; Clinical Trials; Drug Reimbursement; Early Stage; Early Stage Research Funding; Early Stage Funding; Milken Institute; Michael Milken; David Baltimore; Partnering For Cures; National Institutes Of Health; Cancer Care In The U.S.; Cancer Care Services; Policy-making; Health Care and Treatment; Health; Health Testing and Trials; Entrepreneurship; Social Entrepreneurship; Nonprofit Organizations; Policy; Health Industry; United States; District of Columbia
Hamermesh, Richard G., and James Weber. "FasterCures: Removing Barriers to Treatments." Harvard Business School Case 814-003, October 2013.
- May 2012
- Supplement
Westlake Lanes: How Can This Business Be Saved? Spreadsheet for Students (Brief Case)
By: Richard G. Hamermesh and Alisa Zalosh
- November 2012
- Case
Sugar Bowl
By: Richard G. Hamermesh and Alisa Zalosh
Shelby Givens, a recent business school graduate, returned home to Raleigh, North Carolina, to help rescue her family's ailing and outdated bowling alley, Westlake Lanes. Although she cut costs and addressed inefficiencies, moving the business from near-bankruptcy to... View Details
Keywords: Family Business; Entrepreneurship; Operations; Performance; Business Strategy; Corporate Finance; Entertainment and Recreation Industry; Raleigh
Hamermesh, Richard G., and Alisa Zalosh. "Sugar Bowl." Harvard Business School Brief Case 913-537, November 2012.
- November 2008 (Revised January 2010)
- Supplement
Stone Finch, Inc.: Young Division, Old Division, Spreadsheet Supplement for Instructors (Brief Case)
By: Richard G. Hamermesh and Elizabeth Collins
- November 2008 (Revised January 2010)
- Teaching Note
Stone Finch, Inc.: Young Division, Old Division (Brief Case)
By: Richard G. Hamermesh and Elizabeth Collins
Teaching Note for 3214 View Details
- September 2009 (Revised August 2012)
- Case
Novasys Medical
By: Richard G. Hamermesh and Lauren Barley
Novasys has developed a new medical device and procedure for the treatment of female stress urinary incontinence that is cheaper and can be performed in doctors' offices. In spite of FDA approval, the American Medical Association has been unwilling to approve the... View Details
Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Policy; Health Care and Treatment; Health Disorders; Product Development; Business and Government Relations; Medical Devices and Supplies Industry; United States
Hamermesh, Richard G., and Lauren Barley. "Novasys Medical." Harvard Business School Case 810-027, September 2009. (Revised August 2012.)
- September 2006
- Teaching Note
Corporate Venture Capital at Eli Lilly (TN)
By: Richard G. Hamermesh and Erin Seefeld
- January 2006 (Revised May 2007)
- Supplement
Endo Pharmaceuticals (F): Appeals Court Ruling
By: Richard G. Hamermesh and Brian DeLacey
Hamermesh, Richard G., and Brian DeLacey. "Endo Pharmaceuticals (F): Appeals Court Ruling." Harvard Business School Supplement 806-082, January 2006. (Revised May 2007.)
- September 2005 (Revised June 2006)
- Case
WuXi PharmaTech
By: Richard G. Hamermesh and Simin Zhou
WuXi Pharmatech has gone from zero to $21 million in sales in three years. The company must decide its growth strategy and how best to finance and organize for rapid growth. View Details
Keywords: Growth Management; Capital Markets; Problems and Challenges; Pharmaceutical Industry; China
Hamermesh, Richard G., and Simin Zhou. "WuXi PharmaTech." Harvard Business School Case 806-003, September 2005. (Revised June 2006.)
- February 2001 (Revised April 2001)
- Case
Balance, Inc. (B)
By: Richard G. Hamermesh and Michele Lutz
Supplements the (A) case. View Details
Hamermesh, Richard G., and Michele Lutz. "Balance, Inc. (B)." Harvard Business School Case 801-170, February 2001. (Revised April 2001.)
- January 2001 (Revised May 2001)
- Case
Return Logic, Inc. (B)
By: Richard G. Hamermesh and Michele Lutz
Highlights how multiple rounds of financing work in practice and illustrates how terms agreed to in early-stage financing deals have an impact in later financing rounds. Also illustrates ethical issues that entrepreneurs confront as they build "dot-com" ventures. View Details
Keywords: Venture Capital; Investment Funds; Private Equity; Internet and the Web; Negotiation Deal; Entrepreneurship; Ethics
Hamermesh, Richard G., and Michele Lutz. "Return Logic, Inc. (B)." Harvard Business School Case 801-168, January 2001. (Revised May 2001.)